Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00844532 · ClinicalTrials.gov registry record · Phase 3
Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery.
A Phase 3 study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- Phase 3
- Development phase
- 151
- Enrollment target
NCT00844532 is a Phase 3 study that has completed, run by Abbott Medical Devices. The registered enrollment target is 151 participants.
The verdict
NCT00844532, a Phase 3 study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 151 participants
- Enrollment target
Study Summary
To determine the safety and efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in subjects with atherosclerotic de novo or restenotic lesions in the native common iliac artery and/or native external iliac artery.
Interventions
- DEVICE Absolute Pro™ Peripheral Self-Expanding Stent System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2009-03 |
| Est. Completion | 2014-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00844532
The ClinicalTrials.gov registry entry for NCT00844532 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Absolute Pro™ Peripheral Self-Expanding Stent System is the first listed.
NCT00844532 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00844532 about?
NCT00844532 is a clinical study titled "Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery.". To determine the safety and efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in subjects with atherosclerotic de novo or restenotic lesions in the native common iliac artery and/or native external iliac artery.
What is the current status of trial NCT00844532?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 151 participants. The study started on 2009-03. Estimated completion is 2014-06.
What interventions are being tested in trial NCT00844532?
The interventions under investigation include: Absolute Pro™ Peripheral Self-Expanding Stent System (DEVICE).
Who is sponsoring clinical trial NCT00844532?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.